Marker Therapeutics, Inc.
MRKR· Nasdaq
MRKRMarker Therapeutics, Inc.
Filed Mar 17, 2022 · 10-K · 76 days after period end · 0001410578-22-000418
derived · Computed from the longer spans the company filed.
| Metric | Q4 2021dderived from reported figures | Q4 2020dderived from reported figures | Q4 2019dderived from reported figures | Q4 2018dderived from reported figures |
|---|---|---|---|---|
| Net Income | -$9.76M | -$8.51M | -$5.08M | -$135.56M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Marker Therapeutics, Inc. · CIK 1094038 · Engraved from SEC EDGAR
ended Dec 31, 2021 · filed Mar 17, 2022 · 76 d after period end
